RecruitingPancreatic Carcinoma

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

Eligible age

18+ yrs

Accepts

All genders

Locations

9 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study evaluates individuals without pancreatic cancer, but who have been determined to be at higher-than-average lifetime risk of developing pancreatic cancer to help detect pancreatic cancer or other cancers at an earlier time when they might be more easily treated and cured.

Sponsor: Mayo Clinic

You may qualify if…

✓ PDAC FAMILY HISTORY OR PDAC RELATED GENETIC MUTATIONS:
✓ Age: 50 or older, plus at least one of the following:
✓ Mutation unknown or absent:
✓ 2+ relatives with PDAC on same side of family where 2 affected are first degree related to each other and at least 1 affected is first degree related to subject;
✓ OR 2+ affected first degree relatives \[(FDR), defined as blood related parents, siblings, or children\]
✓ Known pathogenic/likely pathogenic (P/LP) mutation in at least one of the following:
✓ CDKN2A/p16, Peutz-Jeghers syndrome (PJS) serine/threonine kinase 11 (STK11), Hereditary pancreatitis with confirmed protease serine 1 (PRSS1)
✓ OR 1+ or second degree relative (SDR) with PDAC and a known P/LP mutation in one or more of:

You may not qualify if…

✕ Is unable to provide informed consent
✕ Has received a non-autologous bone marrow transplant or has an active hematologic malignancy (i.e., leukemia or lymphoma)
✕ Current or prior history of PDAC or total pancreatectomy
✕ Is currently a prison inmate
✕ Is not able to speak or read English